Retinoic acid receptor γ is a therapeutically targetable driver of growth and survival in prostate cancer

BACKGROUND: Prostate cancer (PC) tissue contains all‐trans retinoic acid (ATRA) at a very low level (10(−9) M), at least an order of magnitude lower than in adjacent normal healthy prostate cells or benign prostate hyperplasia. When this is coupled with deregulated expression of the intracellular li...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrie, Kevin, Urban‐Wójciuk, Zuzanna, Sbirkov, Yordan, Graham, Amy, Hamann, Annika, Brown, Geoffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941583/
https://www.ncbi.nlm.nih.gov/pubmed/32881426
http://dx.doi.org/10.1002/cnr2.1284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941583/
https://www.ncbi.nlm.nih.gov/pubmed/32881426
http://dx.doi.org/10.1002/cnr2.1284

Ejemplares similares